查詢結果分析
相關文獻
- Randomized Comparison of Misoprostol and Dinoprostone for Preinduction Cervical Ripening and Labor Induction
- A Prospective Study of Intravaginal Prostaglandin E[feaf]for Cervical Ripening and Induction of Labor
- Induction of Labor with Intracervical Prostablandin E[feaf]Tablet
- Cochrane Nursing Care Field--Review Summary Castor oil, Bath and/or Enema for Cervical Priming and Induction of Labour
- Survival Advantages and Complications of Adjuvant Therapy in Early-Stage Cervical Cancer with Pelvic Node Metastasis
- Clinincal Characteristics and Management of Enterovesical Fistulas
- Well-Differentiated Papillary Villoglandular Adenocarcinoma of the Uterine Cervix: A Case Report
- 某醫學中心婦女做子宮頸抹片檢查與其影響因素之探討
- Evaluation of Atypical Glandular Cells of Undetermined Significance in Cervical Cytology Screening
- 以皮膚穴道電機能篩檢儀對婦科腫瘤病人治療前後及恢復期之觀察
頁籤選單縮合
題 名 | Randomized Comparison of Misoprostol and Dinoprostone for Preinduction Cervical Ripening and Labor Induction=使用Misoprostol與Dinoprostone於引產前改善子宮頸成熟度以及引產效用之隨機比較 |
---|---|
作 者 | 張炯心; 張峰銘; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 96:5 1997.05[民86.05] |
頁 次 | 頁366-369 |
分類號 | 417.431 |
關鍵詞 | 子宮頸; 成熟度; 引產; Misoprostol; Dinoprostone; Cervical ripening; Labor induction; |
語 文 | 英文(English) |
英文摘要 | This study attempts to evaluate the clinical effects of prostaglandin (PG) E analogues in preinduction cervical ripening and labor induction and to compare the perinatal outcomes of these medications. Sixty women with term singleton pregnancies were randomized to receive dinoprostone vaginal tablets (group I) or misoprostol vaginal tablets (group II). The Bishop scores were evaluated before drug insertion and every 4 hours during induction. Clinical data and perinatal outcomes were also recorded. There were no signficant differences in the preinduction conditions on mean initial Bishop scores between these two groups. Twelve hours after drug insertion, the mean Bishop scores were significantly better in group II (9.7 ± 3.1 vs 7.3 ± 2.5, p<0.05). The mean time from insertion to delivery was shorter in group II (16.5 ± 2.7 h vs25.7 ± 3.8 h, p<0.001). There were no significant differences in spontaneous labor rate, need for oxytocin augmentation, type of delivery, and Doppler flow velocity waveforms of the umbilical artery. The average number of doses given per patient was 1.8 ± 1.4 in group II vs 2.7 ± 0.3 in group I (p<0.05). The perinatal outcome was similar in the two groups. In conclusion, misoprostol not only appears to be a safe and effective agent for cervical ripening and labor induction but is also more efficient than dinoprostone. |
本系統中英文摘要資訊取自各篇刊載內容。